Transport studies with 5-aminosalicylate

European Journal of Clinical Pharmacology

Volumn 62, Issue 10, 2006, Pages 871-875

  Xin, Hua Wen ^a   Schwab, Matthias ^b   Klotz, Ulrich ^b  

^a WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

5 aminosalicylate; Inflammatory bowel disease; Intestinal transport; MRP2; P glycoprotein

Indexed keywords

DIGOXIN; GLYCOPROTEIN P; MESALAZINE; MULTIDRUG RESISTANCE PROTEIN 2;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; CELL STRAIN; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG TRANSPORT; ENTERITIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE ABSORPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL LINE; CELL MEMBRANE PERMEABILITY; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INULIN; LLC-PK1 CELLS; MEMBRANE TRANSPORT PROTEINS; MESALAMINE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; SWINE; TRANSFECTION; TRITIUM;

EID: 33749483489     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0182-3     Document Type: Article

References (17)

1. Artursson P, Karlsson J (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 29:880-885
2. Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF (2002) Piperine, a major constituent of black pepper inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302:645-650
3. Dilger K, Schwab M, Fromm MF (2004) Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein. Inflamm Bowel Dis 10:578-583
4. Evers R, Kool M, van Deemter L, Janssen H, Calafat J, Oomen LC, Paulusma CC, Oude Elferink RP, Baas F, Schinkel AH, Borst P (1998) Drug export activity of the human canalicular multi-specific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest 101:1310-1319
5. Farrell RJ, Murphy A, Long A, Donnelly S, Cherikuri A, O'Toole D, Mahmud N, Keeling PW, Weir DG, Kelleher D (2000) High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 118:279-288
6. Farrell RJ, Menconi MJ, Keates AC, Kelly CP (2002) P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes. Aliment Pharmacol Ther 16:1021-1031
7. Goebell H, Klotz U, Nehlsen B, Layer P (1993) Oroileal transit of slow release 5-aminosalicylic acid. Gut 34:669-675
8. Hidalgo IJ, Raub TJ, Borchardt RT (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96:736-749
9. Ho GT, Moodie FM, Satsangi J (2003) Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut 52:759-766
10. Klotz U (2000) The role of aminosalicylates at the beginning of the new millenium in the treatment of chronic inflammatory bowel disease. Eur J Clin Pharmacol 56:353-362
11. Klotz U, Schwab M (2005) Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Delivery Rev 57:267-279
12. Layer PH, Goebell H, Keller J, Dignass A, Klotz U (1995) Delivery and fate of oral mesalamine microgranules within the human small intestine. Gastroenterology 108:1427-1433
13. Liang E, Proudfoot J, Yazdanian M (2000) Mechanisms of transport and structure permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers. Pharm Res 17:1168-1174
14. Suzuki H, Sugiyama Y (2000) Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci 12:3-12
15. Tang F, Horie K, Borchardt RT (2002) Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa? Pharm Res 19:773-779
16. Yacyshyn B, Maksymowych W, Bowen-Yacyshyn MB (1999) Differences in P-glycoprotein-170 expression and activity between Crohn's disease and ulcerative colitis. Human Immunol 60:677-687
17. Zhou SY, Fleisher D, Pao LH, Li C, Winward B, Zimmermann EM (1999) Intestinal metabolism and transport of 5-aminosalicylate. Drug Metab Disp 27:479-485